Navigation Links
New Drug Mix to Extend Life of Transplanted Kidneys

It is great news for kidney recipients as well as those on the waiting list. Scientists now announce the extended life spans of transplanted kidneys// by a priceless two times, through a mix of varied drugs.

Scientists from the University Hospital in Cardiff who detailed their work in an organ transplant study entitled ‘Symphony’, say a combination of drugs including the standard one CellCept, will do the trick. The study involved 1,645 kidney patients from 15 countries.

It was seen that early organ rejection was reduced by 52 percent compared with the other combinations tested, with far less toxic side effects.

Consequentially, it was predicted that the normal 10-year lifespan of a transplanted kidney would be extended to 20 years or more.

The scientists reported that used across the UK, the treatment protocol could save the NHS more than 100 kidneys a year. In addition, lesser transplant patients with "old" organs would have to be found new replacements, easing the pressure on waiting lists. The number of patients without functioning kidneys having to rely on dialysis would also be reduced, the scientists stressed.

Between 2005 and 2006, a total of 1,783 British patients received new kidneys.

The NHS list of patients waiting for new kidneys now stands at 5,971, but the total number of people in the UK needing a kidney, including those who do not meet the strict criteria for transplants laid down by the NHS, is estimated to be about 20,000.
AN
'"/>




Page: 1

Related medicine news :

1. Extended Therapy for Blood Clots
2. Genes to Extend Longevity Discovered
3. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
4. Drug Courts In Europe Extended For Three More Years
5. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
6. Extend Workers Compensation To Firefighters. Pleads Son
7. Boots Store Also Extend Its Services to the Hospital Sector
8. Damage Due to MS Might Extend Into Larger Portions Of The Normal Brain
9. Imperative to Extend Reach of Federal Health Insurance Schemes for children
10. Tenure of Mental Health CommissionExtended
11. Irish Medicines Board Extends Paracetamol Recall To All Batches
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a ... and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts ... hospital and decide to donate. , “Women’s Hospital at Renaissance has been a ...
(Date:4/28/2017)... Yorba Linda, Ca (PRWEB) , ... April 28, ... ... entities with cardiac or hERG liability could substantially improve drug safety and minimize ... will be provided for validating ion channel inhibition using cell lines and for ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: